GSK and Zhifei announced exclusive strategic vaccine partnership in China with $3 billion
On Oct. 9, 2023, GlaxoSmithKline (GSK) announced that it had reached an exclusive agreement with Chongqing Zhifei Biological…
-
-
Study confirmed safety of shingles vaccine
On Oct. 20, 2022, published results supported previous findings that the recombinant zoster vaccine Shingrix, recommended by the…
-
Biotechnology | Disease | FDA | Vaccine
FDA licensed Shingrix, the new shingles vaccine from GlaxoSmithKline, for use in adults age 50 and older
On Oct. 23, 2017, GlaxoSmithKline announced the U.S. Food and Drug Administration (FDA) had approved Shingrix (Zoster Vaccine…
-
Zostavax was approved by the FDA to prevent shingles in individuals 50 years of age and older
On Mar. 24, 2011, Zostavax, manufactured by Merck of Whitehouse Station, New Jersey, was approved by the U.S….
